Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Omeros Corp (NASDAQ:OMER)

16.47
Delayed Data
As of 3:59pm ET
 +0.18 / +1.10%
Today’s Change
7.20
Today|||52-Week Range
17.19
+66.03%
Year-to-Date
No recent news for Omeros Corp.

Today’s Trading

Previous close16.29
Today’s open16.65
Day’s range16.33 - 16.69
Volume298,585
Average volume (3 months)517,348
Market cap$715.8M
Dividend yield--
Data as of 3:59pm ET, 04/27/2017

Growth & Valuation

Earnings growth (last year)+17.50%
Earnings growth (this year)+25.15%
Earnings growth (next 5 years)+85.00%
Revenue growth (last year)+208.07%
P/E ratioNM
Price/Sales9.64
Price/Book--

Competitors

 Today’s
change
Today’s
% change
TGTXTG Therapeutics Inc-0.20-1.65%
AMPHAmphastar Pharmaceut...-0.16-1.04%
RVNCRevance Therapeutics...0.000.00%
CYTKCytokinetics Inc+0.10+0.59%
Data as of 3:59pm ET, 04/27/2017

Financials

Next reporting dateMay 16, 2017
EPS forecast (this quarter)-$0.35
Annual revenue (last year)$41.6M
Annual profit (last year)-$66.7M
Net profit margin-160.38%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Gregory A. Demopulos
CFO, Treasurer, Chief Accounting Officer &
VP
Michael A. Jacobsen
Corporate headquarters
Seattle, Washington

Forecasts